Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Microscopic Polyangiitis

What is Microscopic Polyangiitis?

Microscopic Polyangiitis is a rare autoimmune disease. This disease can affect many of the body's organ systems including (but not limited to) the kidneys, nervous system (particularly the peripheral nerves, as opposed to the brain or spinal cord), skin, and lungs

 

Microscopic Polyangiitis is a rare autoimmune disease. This disease can affect many of the body's organ systems including (but not limited to) the kidneys, nervous system (particularly the peripheral nerves, as opposed to the brain or spinal cord), skin, and lungs
Acknowledgement of Microscopic Polyangiitis has not been added yet.
7.5http://www.orpha.net
Synonyms for Microscopic Polyangiitis has not been added yet.
The cause of MPA is unknown. The immune system is thought to play a critical role in the development of MPA. It is thought that the immune system becomes overactive and causes blood vessel and tissue inflammation, which leads to organ damage. It is not known what causes the immune system to become overactive.
Symptoms for Microscopic Polyangiitis has not been added yet.
Diagnosis of Microscopic Polyangiitis has not been added yet.
Diagnostic tests of Microscopic Polyangiitis has not been added yet
MPA is treated with medications that suppress the immune system, which can lower an individual's resistance to infections. There are a variety of immune suppressing medications that are used in MPA; however, resources state that a steroid (usually prednisone) and a medication toxic to cells (usually starting with cyclophosphamide) are typically prescribed first. The goal of treatment is to stop all of the organ damage that occurs as a result of MPA
The prognosis for MPA depends on the severity of the condition. The best prognosis is made when treatment has been promptly initiated and is carefully monitored by a physician who is knowledgeable about MPA. With treatment, 75 percent of individuals achieve complete remission. After achieving remission, it is possible for MPA to recur (often referred to as a “relapse”). Relapses occur in about 50% of people with MPA. Achieving remission is again possible for most people with MPA
Tips or Suggestions of Microscopic Polyangiitis has not been added yet.
References of Microscopic Polyangiitis has not been added yet.
Halfway point Created by Tlp708
Last updated 25 Nov 2015, 08:58 PM

Posted by joefrancis
25 Nov 2015, 08:58 PM

Hello, I'm Joe, I was diagnosed March 2011 and life has not been the same since.If anyone would like to chat or discuss here I'm up for it. My email is joefranciscowboy@yahoo.ca Have a great day!

Posted by Tlp708
28 Jun 2013, 07:18 PM

I am halfway through treatment for MPA diagnosed in March. All is going well and I'm hopeful for remission that lasts in a few months. I see that there is one other person in this community...would welcome your comments if you want to post something.

Community External News Link
Title Date Link
Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

Hello, I am not sure if my ...
I have a rare vascular dise...
I'll let you know when I know.

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.

Discussion Forum

Halfway point

Created by Tlp708 | Last updated 25 Nov 2015, 08:58 PM


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.